AI assistant
Sending…
Pluri Inc. — Director's Dealing 2013
Mar 25, 2013
6990_dirs_2013-03-25_cdd1531b-eba5-4ac3-a702-e52a23108763.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PLURISTEM THERAPEUTICS INC (PSTI)
CIK: 0001158780
Period of Report: 2013-03-21
Reporting Person: BEN-YORAM ISRAEL (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-03-21 | Common Stock | M | 27500 | $0.62 | Acquired | 320208 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-03-21 | Stock option (right to buy) | $0.62 | M | 27500 | Disposed | 2018-10-30 | Common Stock (27500) | Direct |
Footnotes
F1: The options vested as follows: 25% on 4/30/2009 and the remaining options vested monthly, in equal installments over 18 months until 10/30/2010.
More from Pluri Inc.
Regulatory Filings
2026
Jun 2
Report Publication Announcement
2026
Jun 2
Report Publication Announcement
2026
Jun 1
Capital/Financing Update
2026
Jun 1
Capital/Financing Update
2026
Jun 1
Report Publication Announcement
2026
May 14
Interim / Quarterly Report
2026
May 14
Interim / Quarterly Report
2026
May 14
Annual Report
2026
Apr 23
Report Publication Announcement
2026
Apr 23